Cargando…
The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection
Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They m...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548687/ https://www.ncbi.nlm.nih.gov/pubmed/37789431 http://dx.doi.org/10.1186/s12985-023-02183-z |
_version_ | 1785115324315598848 |
---|---|
author | Faghihkhorasani, Amirhosein Ahmed, Hanan Hassan Mashool, Noor Muhammad Alwan, Mariem Assefi, Marjan Adab, Aya Hussein Yasamineh, Saman Gholizadeh, Omid Baghani, Moein |
author_facet | Faghihkhorasani, Amirhosein Ahmed, Hanan Hassan Mashool, Noor Muhammad Alwan, Mariem Assefi, Marjan Adab, Aya Hussein Yasamineh, Saman Gholizadeh, Omid Baghani, Moein |
author_sort | Faghihkhorasani, Amirhosein |
collection | PubMed |
description | Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10548687 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-105486872023-10-05 The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection Faghihkhorasani, Amirhosein Ahmed, Hanan Hassan Mashool, Noor Muhammad Alwan, Mariem Assefi, Marjan Adab, Aya Hussein Yasamineh, Saman Gholizadeh, Omid Baghani, Moein Virol J Review Viral infections in humans are responsible for fatalities worldwide and contribute to the incidence of various human ailments. Controllable targeted medicine delivery against many illnesses, including viral infection, may be significantly aided by using bacteria and bacteria-derived products. They may accumulate in diseased tissues despite physical obstacles, where they can launch antiviral immunity. The ability to genetically and chemically modify them means that vaccinations against viral infections may be manufactured and delivered to affected tissues more safely and effectively. The objective of this study is to provide an overview of the latest advancements in the field of utilizing bacteria and bacterial derivatives as carriers for administering medication to treat viral diseases such as SARS-CoV-2, hepatitis B virus, hepatitis C virus, human immunodeficiency virus, human papillomavirus, influenza, and Ebola virus. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-10-03 /pmc/articles/PMC10548687/ /pubmed/37789431 http://dx.doi.org/10.1186/s12985-023-02183-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Faghihkhorasani, Amirhosein Ahmed, Hanan Hassan Mashool, Noor Muhammad Alwan, Mariem Assefi, Marjan Adab, Aya Hussein Yasamineh, Saman Gholizadeh, Omid Baghani, Moein The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
title | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
title_full | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
title_fullStr | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
title_full_unstemmed | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
title_short | The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
title_sort | potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10548687/ https://www.ncbi.nlm.nih.gov/pubmed/37789431 http://dx.doi.org/10.1186/s12985-023-02183-z |
work_keys_str_mv | AT faghihkhorasaniamirhosein thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT ahmedhananhassan thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT mashoolnoormuhammad thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT alwanmariem thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT assefimarjan thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT adabayahussein thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT yasaminehsaman thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT gholizadehomid thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT baghanimoein thepotentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT faghihkhorasaniamirhosein potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT ahmedhananhassan potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT mashoolnoormuhammad potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT alwanmariem potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT assefimarjan potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT adabayahussein potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT yasaminehsaman potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT gholizadehomid potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection AT baghanimoein potentialuseofbacteriaandbacterialderivativesasdrugdeliverysystemsforviralinfection |